Neuralink to Begin High-Volume Production in 2026

Elon Musk announced on December 31, 2025, that his neurotechnology company Neuralink plans to begin high-volume production of its brain-computer interface devices and transition to a fully automated surgical procedure in 2026, marking a significant step toward wider deployment of the implant.

The announcement, shared in a post on the social media platform X, comes as Neuralink shifts from limited clinical trials to scaled manufacturing. The device, a coin-sized implant, is surgically placed in the brain and connected via flexible threads containing hundreds of microscopic electrodes thinner than a human hair. These electrodes detect neural signals and translate them into digital commands, enabling users to control computers or external devices through thought alone. The implant targets individuals with severe paralysis or spinal cord injuries, aiming to restore digital and physical autonomy.

Neuralink's human trials began in 2024, following an initial rejection of the company's application by the U.S. Food and Drug Administration in 2022. Regulators had raised concerns about the device's lithium battery, the implant removal process, and surgical precision. After addressing these...